This site is intended for health professionals only

Editor’s pick

Ustekinumab in the treatment of moderate-severe psoriasis
Ustekinumab in the treatment of moderate-severe psoriasis
Research is big business
Research is big business
A step forward in managing severe psoriasis in children
A step forward in managing severe psoriasis in children
Cinema campaign against fake drugs
Cinema campaign against fake drugs
Therabel wins Dyloject UK contract
Therabel wins Dyloject UK contract
Link found between mental disorders
Link found between mental disorders
DH awards Novartis huge cash sum
DH awards Novartis huge cash sum
US acts against counterfeit drugs
US acts against counterfeit drugs
Study confirms Sandostatin LAR controls rare gastrointestinal tumor growth
Study confirms Sandostatin LAR controls rare gastrointestinal tumor growth
Postitive trial results for Novartis
Postitive trial results for Novartis
Gene fusion an indicator of cancer
Gene fusion an indicator of cancer
Alzheimer’s linked to faulty gene
Alzheimer’s linked to faulty gene
1 … 156 157 158 159 160 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x